Literature DB >> 1914560

Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome?

D Schuller1, J P Mitchell, F S Calandrino, D P Schuster.   

Abstract

STUDY
OBJECTIVE: To evaluate the importance of fluid balance and changes in extravascular lung water (EVLW) on survival in the ICU and short-term outcome in patients with pulmonary edema.
DESIGN: Retrospective analysis of data (sorting by survival and "treatment received") from a recent randomized controlled trial of fluid restriction in this population.
SETTING: Medical ICU of a university-affiliated, tertiary-care medical center. PATIENTS: Eighty-nine patients (from the previously mentioned study) requiring pulmonary artery catheterization with abnormally high EVLW (greater than 7 ml/kg). MEASUREMENTS AND
RESULTS: When analyzed by survival, the survivors had no significant fluid gain or change in EVLW but decreased wedge pressure and body weight, compared to nonsurvivors. When analyzed by fluid balance, patients who gained less than 1 L of fluid by 36 hours into the study had a better rate of survival (74 percent) than the rest (50 percent; p less than 0.05). Also, the median duration of days on the ventilator, ICU days, and days of hospitalization was approximately half as long for each variable in the group with less than 1 L of fluid gain. Even accounting for baseline differences in the severity of illness, fluid balance was an independent predictor of survival (p less than 0.05). When analyzed by whether or not EVLW decreased by more than 15 percent between the first and last measurement, only patients with ARDS or sepsis had decreased days on the ventilator and ICU days.
CONCLUSIONS: These data support the concept that positive fluid balance per se is at least partially responsible for poor outcome in patients with pulmonary edema and defend the strategy of attempting to achieve a negative fluid balance if tolerated hemodynamically.

Entities:  

Mesh:

Year:  1991        PMID: 1914560     DOI: 10.1378/chest.100.4.1068

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  48 in total

Review 1.  The pulmonary physician in critical care - part 9: non-ventilatory strategies in ARDS.

Authors:  J Cranshaw; M J D Griffiths; T W Evans
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

2.  Effects of two different dosing regimens of terlipressin on organ functions in ovine endotoxemia.

Authors:  Matthias Lange; Christian Ertmer; Sebastian Rehberg; Andrea Morelli; Gabriele Köhler; Tim G Kampmeier; Hugo Van Aken; Martin Westphal
Journal:  Inflamm Res       Date:  2010-12-29       Impact factor: 4.575

3.  Increased incidence of diuretic use in critically ill obese patients.

Authors:  Emma J de Louw; Pepijn O Sun; Joon Lee; Mengling Feng; Roger G Mark; Leo Anthony Celi; Kenneth J Mukamal; John Danziger
Journal:  J Crit Care       Date:  2015-02-07       Impact factor: 3.425

Review 4.  The dopamine paradox in lung and kidney epithelia: sharing the same target but operating different signaling networks.

Authors:  Alejandro M Bertorello; Jacob I Sznajder
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11       Impact factor: 6.914

Review 5.  Renal replacement therapy review: past, present and future.

Authors:  Geoffrey M Fleming
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

6.  Time out for vasopressors in increased microvascular permeability?

Authors:  Pierre Asfar; Peter Radermacher; Gernot Marx
Journal:  Intensive Care Med       Date:  2007-07-11       Impact factor: 17.440

7.  A multicenter international survey of renal supportive therapy during ECMO: the Kidney Intervention During Extracorporeal Membrane Oxygenation (KIDMO) group.

Authors:  Geoffrey M Fleming; David J Askenazi; Brian C Bridges; David S Cooper; Mathew L Paden; David T Selewski; Michael Zappitelli
Journal:  ASAIO J       Date:  2012 Jul-Aug       Impact factor: 2.872

Review 8.  Acute lung injury: epidemiology, pathogenesis, and treatment.

Authors:  Elizabeth R Johnson; Michael A Matthay
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-08       Impact factor: 2.849

Review 9.  Prevention and therapy of the adult respiratory distress syndrome.

Authors:  B Temmesfeld-Wollbrück; D Walmrath; F Grimminger; W Seeger
Journal:  Lung       Date:  1995       Impact factor: 2.584

10.  Pulmonary vascular permeability changes in an ovine model of methicillin-resistant Staphylococcus aureus sepsis.

Authors:  Collette C Jonkam; Kamna Bansal; Daniel L Traber; Atsumori Hamahata; Marc O Maybauer; Dirk M Maybauer; Robert A Cox; Matthias Lange; Rhykka L Connelly; Lillian D Traber; Clarisse D Djukom; John R Salsbury; David N Herndon; Perenlei Enkhbaatar
Journal:  Crit Care       Date:  2009-02-17       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.